Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company AdiuTide Pharmaceuticals GmbH
DescriptionB-class CpG oligonucleotide (CpG ODN)
Molecular Target Toll-like receptor 9 (TLR9)
Mechanism of Action 
Therapeutic ModalityNucleic acid
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today